You have free access to this content

American Journal of Transplantation

Cover image for Vol. 12 Issue 12

December 2012

Volume 12, Issue 12

Pages 3167–3470

  1. The AJT Report

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Original Articles
    8. Brief Communications
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    1. You have free access to this content
      The AJT Report: News and issues that affect organ and tissue transplantation (pages 3167–3168)

      SUE PONDROM

      Version of Record online: 30 NOV 2012 | DOI: 10.1111/ajt.12039

      Who do you think you are? Microbes in humans outnumber human cells 10 to one, and “The AJT Report” looks at their potential impact on transplant outcomes. Also in this month's issue, the 2012 Lasker-DeBakey prize is awarded to two surgeon-scientists who developed safe liver transplantation, Sir Roy Calne and Thomas Starzl.

  2. Literature Watch

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Original Articles
    8. Brief Communications
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    1. You have free access to this content
      LITERATURE Watch: Implications for transplantation (page 3169)

      ROBERT L. FAIRCHILD, JONATHAN S. BROMBERG and Jonathan S. Bromberg

      Version of Record online: 30 NOV 2012 | DOI: 10.1111/ajt.12040

      Several studies expose two novel intracellular molecular patterns that initiate inflammatory responses, and specifically discuss the mitochondrial damage and cell necrosis initiated during reperfusion of ischemic tissues.

  3. Editorials

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Original Articles
    8. Brief Communications
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    1. You have free access to this content
      Assessing 30-Day Hospital Readmission After Renal Transplantation: A Complex Task (pages 3171–3172)

      B. Kaplan and J. F. Sweeney

      Version of Record online: 30 NOV 2012 | DOI: 10.1111/j.1600-6143.2012.04289.x

      This editorial discusses the complex issues surrounding assessment of hospital readmission following renal transplantation, a metric likely to influence reimbursement in the future. See article by McAdams-DeMarco et al on page 3283.

    2. You have free access to this content
      Challenges to Doing Genetic Association Studies in Transplantation (pages 3173–3175)

      D. R. Salomon

      Version of Record online: 30 NOV 2012 | DOI: 10.1111/j.1600-6143.2012.04267.x

      The author discusses some of the challenges in the optimal design and conduct of genome-wide association studies and their resultant huge amounts of data in the context of the article by Khush et al (page 3377).

  4. Minireviews

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Original Articles
    8. Brief Communications
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    1. You have free access to this content
      Liver Defatting: An Alternative Approach to Enable Steatotic Liver Transplantation (pages 3176–3183)

      N. I. Nativ, T. J. Maguire, G. Yarmush, D. L. Brasaemle, S. D. Henry, J. V. Guarrera, F. Berthiaume and M. L. Yarmush

      Version of Record online: 11 OCT 2012 | DOI: 10.1111/j.1600-6143.2012.04288.x

      • image
      • image

      This minireview discusses the mechanisms whereby macrosteatosis exacerbates hepatic ischemia-reperfusion injury during liver transplantation, and current approaches to address this problem, including metabolically induced defatting.

    2. You have free access to this content
      The Nephroprotective Properties of Recombinant Human Erythropoietin in Kidney Transplantation: Experimental Facts and Clinical Proofs (pages 3184–3190)

      N. Pallet, M. Rabant, C. Legendre, F. Martinez and G. Choukroun

      Version of Record online: 11 OCT 2012 | DOI: 10.1111/j.1600-6143.2012.04287.x

      The authors provide a survey of the rationale for the administration of recombinant human erythropoietin in the setting of kidney transplantation, and discuss intriguing findings from clinical trials and discrepancies between promising experimental results and negative clinical studies.

  5. Special Articles

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Original Articles
    8. Brief Communications
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    1. You have free access to this content
      Kidney, Pancreas and Liver Allocation and Distribution in the United States (pages 3191–3212)

      J. M. Smith, S. W. Biggins, D. G. Haselby, W. R. Kim, J. Wedd, K. Lamb, B. Thompson, D. L. Segev, S. Gustafson, R. Kandaswamy, P. G. Stock, A. J. Matas, C. J. Samana, E. F. Sleeman, D. Stewart, A. Harper, E. Edwards, J. J. Snyder, B. L. Kasiske and A. K. Israni

      Version of Record online: 16 NOV 2012 | DOI: 10.1111/j.1600-6143.2012.04259.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image

      This special article describes the history, current status, and future direction of policies regarding the allocation of kidneys, livers, and pancreata for transplant in the United States, reflecting efforts to optimize allocation to help ensure effectiveness, efficiency, and equity of organ sharing. Also see article by Colvin-Adams et al on page 3213.

    2. You have free access to this content
      Lung and Heart Allocation in the United States (pages 3213–3234)

      M. Colvin-Adams, M. Valapour, M. Hertz, B. Heubner, K. Paulson, V. Dhungel, M. A. Skeans, L. Edwards, V. Ghimire, C. Waller, W. S. Cherikh, B. L. Kasiske, J. J. Snyder and A. K. Israni

      Version of Record online: 13 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04258.x

      • image
      • image
      • image
      • image
      • image
      • image

      This special article examines the development of US lung and heart allocation policy, evaluates the application of the current policy to clinical practice, and explores future directions, reflecting ongoing efforts to ensure that lung and heart allocation policies are equitable and current. Also see article by Smith et al on page 3191.

  6. Original Articles

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Original Articles
    8. Brief Communications
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    1. Basic Science

      You have free access to this content
      Targeting Cells Causing Split Tolerance Allows Fully Allogeneic Islet Survival With Minimal Conditioning in NOD Mixed Chimeras (pages 3235–3245)

      D. P. Al-Adra, R. Pawlick, A. M. J. Shapiro and C. C. Anderson

      Version of Record online: 13 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04260.x

      • image
      • image
      • image
      • image
      • image

      The authors show, in the NOD model of type-1 diabetes that is highly resistant to mixed chimerism approaches to prevent islet rejection, that a nonmyeloablative protocol based on depleting cells allows longterm mixed chimerism and fully allogeneic donor islet survival.

    2. You have free access to this content
      Successful Transplantation of Reduced-Sized Rat Alcoholic Fatty Livers Made Possible by Mobilization of Host Stem Cells (pages 3246–3256)

      M. Hisada, Y. Ota, X. Zhang, A. M. Cameron, B. Gao, R. A. Montgomery, G. M. Williams and Z. Sun

      Version of Record online: 20 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04265.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image

      Improved survival with transplantation of reduced-sized alcoholic fatty liver grafts compares to fatty whole grafts via mobilization of host bone marrow stem cells in rats.

    3. You have free access to this content
      Tauroursodeoxycholic Acid Affects PPARγ and TLR4 in Steatotic Liver Transplantation (pages 3257–3271)

      M. B. Jiménez-Castro, M. Elias-Miro, M. Mendes-Braz, A. Lemoine, A. Rimola, J. Rodés, A. Casillas-Ramírez and C. Peralta

      Version of Record online: 20 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04261.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image

      Tauroursodeoxycholic acid reduces PPARγ, and this in turn up-regulates the TLR4 pathway, thus protecting steatotic liver grafts in syngeneic and allogeneic liver transplantation.

    4. You have free access to this content
      Porcine Sialoadhesin: A Newly Identified Xenogeneic Innate Immune Receptor (pages 3272–3282)

      L. G. Brock, P. L. Delputte, J. P. Waldman, H. J. Nauwynck and M. A. Rees

      Version of Record online: 7 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04247.x

      • image
      • image
      • image
      • image
      • image

      The authors find that porcine sialoadhesin mediates porcine macrophage binding of human erythrocytes, and currently limits the development of extracorporeal porcine liver perfusion as a bridge to liver allotransplantation for patients with fulminant hepatic failure.

    5. Clinical Science

      You have free access to this content
      Early Hospital Readmission After Kidney Transplantation: Patient and Center-Level Associations (pages 3283–3288)

      M. A. McAdams-DeMarco, M. E. Grams, E. C. Hall, J. Coresh and D. L. Segev

      Version of Record online: 27 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04285.x

      • image

      In a national study of longitudinal Medicare claims data, the authors find that nearly one-third of kidney transplant recipients were readmitted within 30 days of transplantation, and that recipient and transplant factors but not center-level factors influenced the risk of readmission. See editorial by Kaplan and Sweeney on page 3171.

    6. You have free access to this content
      Twenty-Year Survivors of Kidney Transplantation (pages 3289–3295)

      C. Traynor, A. Jenkinson, Y. Williams, P. O’Kelly, D. Hickey, M. Denton, C. Magee and P. J. Conlon

      Version of Record online: 4 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04236.x

      • image
      • image
      • image

      This retrospective, single-center study of kidney transplant recipients with 20 years of allograft function identifies clinical factors associated with graft survival and a high rate of morbidity in transplant survivors.

    7. You have free access to this content
      The Natural History of Clinical Operational Tolerance After Kidney Transplantation Through Twenty-Seven Cases (pages 3296–3307)

      S. Brouard, A. Pallier, K. Renaudin, Y. Foucher, R. Danger, A. Devys, A. Cesbron, C. Guillot-Guegen, J. Ashton-Chess, S. Le Roux, J. Harb, G. Roussey, J.-F. Subra, F. Villemain, C. Legendre, F.J. Bemelman, G. Orlando, A. Garnier, H. Jambon, H. Le Monies De Sagazan, L. Braun, C. Noël, E. Pillebout, M.-C. Moal, C. Cantarell, A. Hoitsma, M. Ranbant, A. Testa, J.-P. Soulillou and M. Giral

      Version of Record online: 13 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04249.x

      • image
      • image

      The authors report clinical parameters from a European cohort of 27 kidney recipients displaying operational tolerance, compared to cohorts of immunosuppressed kidney recipients and patients who stopped their immunosuppressive drugs and rejected their grafts.

    8. You have free access to this content
      De Novo Kidney Graft Tumors: Results From a Multicentric Retrospective National Study (pages 3308–3315)

      X. Tillou, A. Doerfler, S. Collon, F. Kleinclauss, J.-J. Patard, L. Badet, B. Barrou, M. Audet, H. Bensadoun, E. Berthoux, P. Bigot, J.-M. Boutin, Y. Bouzguenda, D. Chambade, R. Codas, J. Dantal, J. Deturmeny, M. Devonec, F. Dugardin, J.-M. Ferrière, A. Erauso, B. Feuillu, M. Gigante, L. Guy, G. Karam, T. Lebret, Y. Neuzillet, C. Legendre, T. Perez, J.-P. Rerolle, L. Salomon, F. Sallusto, C. Sénéchal, N. Terrier, R. Thuret, G. Verhoest, J. Petit and members of “Comité de Transplantation de l’Association Française d’Urologie (CTAFU)”

      Version of Record online: 7 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04248.x

      • image

      This retrospective study shows that renal cell carcinomas arising in renal allografts appear most often as small, incidental, papillary type, low stage and low grade tumors with good oncological outcomes, except when symptomatic, justifying a conservative treatment approach.

    9. You have free access to this content
      A 1-Year Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Ibandronate on Bone Loss Following Renal Transplantation (pages 3316–3325)

      K. T. Smerud, S. Dolgos, I. C. Olsen, A. Åsberg, S. Sagedal, A. V. Reisæter, K. Midtvedt, P. Pfeffer, T. Ueland, K. Godang, J. Bollerslev and A. Hartmann

      Version of Record online: 4 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04233.x

      • image
      • image

      This prospective, randomized, double-blind, placebo-controlled clinical trial of ibandronate as add-on to calcium and calcitriol in renal transplant recipients with early stable renal function shows that calcium and calcitriol supplementation maintain bone mineral density over 12 months, whereas ibandronate adds a significantly although modest protective effect against bone loss.

    10. You have free access to this content
      Lower Calcineurin Inhibitor Doses in Older Compared to Younger Kidney Transplant Recipients Yield Similar Troughs (pages 3326–3336)

      P. A. Jacobson, D. Schladt, W. S. Oetting, R. Leduc, W. Guan, A. J. Matas and A. Israni

      Version of Record online: 4 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04232.x

      • image
      • image

      This study demonstrates that elderly kidney transplant recipients receive significantly lower doses of calcineurin inhibitors than younger recipients but yet maintain higher trough concentrations, suggesting age-related changes in metabolism.

    11. You have free access to this content
      Eculizumab for Atypical Hemolytic Uremic Syndrome Recurrence in Renal Transplantation (pages 3337–3354)

      J. Zuber, M. Le Quintrec, S. Krid, C. Bertoye, V. Gueutin, A. Lahoche, N. Heyne, G. Ardissino, V. Chatelet, L.-H. Noël, M. Hourmant, P. Niaudet, V. Frémeaux-Bacchi, E. Rondeau, C. Legendre, C. Loirat and the French Study Group for Atypical HUS

      Version of Record online: 7 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04252.x

      • image
      • image
      • image
      • image

      The authors report on a cohort of 22 renal transplant recipients treated with eculizumab for the prevention or treatment of atypical hemolytic uremic syndrome recurrence, and highlight the efficiency of complement blockade with a better recovery of kidney function following early initiation of treatment.

    12. You have free access to this content
      Posttransplant De Novo Donor-Specific HLA Antibodies Identify Pediatric Kidney Recipients at Risk for Late Antibody-Mediated Rejection (pages 3355–3362)

      F. Ginevri, A. Nocera, P. Comoli, A. Innocente, M. Cioni, A. Parodi, I. Fontana, A. Magnasco, A. Nocco, A. Tagliamacco, A. Sementa, P. Ceriolo, L. Ghio, M. Zecca, M. Cardillo, G. Garibotto, G. M. Ghiggeri and F. Poli

      Version of Record online: 7 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04251.x

      • image
      • image
      • image
      • image

      This study of de novo anti-HLA antibody monitoring in pediatric kidney recipients demonstrates an increased incidence of late humoral rejection and poorer outcome in patients developing donor-specific antibodies.

    13. You have free access to this content
      Advantage of Rapamycin Over Mycophenolate Mofetil When Used With Tacrolimus for Simultaneous Pancreas Kidney Transplants: Randomized, Single-Center Trial at 10 Years (pages 3363–3376)

      G. Ciancio, J. Sageshima, L. Chen, J. J. Gaynor, L. Hanson, L. Tueros, E. Montenora Velarde, C. Gomez, W. Kupin, G. Guerra, A. Mattiazzi, A. Fornoni, A. Pugliese, D. Roth, M. Wolf and G. W. Burke III

      Version of Record online: 4 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04235.x

      • image
      • image
      • image
      • image
      • image

      This 10-year study of simultaneous pancreas–kidney transplantation shows that rapamycin in combination with tacrolimus was better tolerated and more effective than mycophenolate mofetil, although overall patient and allograft survival were equivalent.

    14. You have free access to this content
      Beta-Adrenergic Receptor Polymorphisms and Cardiac Graft Function in Potential Organ Donors (pages 3377–3386)

      K. K. Khush, L. Pawlikowska, R. L. Menza, B. A. Goldstein, V. Hayden, J. Nguyen, H. Kim, A. Poon, A. Sapru, M. A. Matthay, P. Y. Kwok, W. L. Young, L. A. Baxter-Lowe and J. G. Zaroff

      Version of Record online: 20 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04266.x

      • image
      • image
      • image

      A genetics study performed in 1,400 potential organ donors reveals possible associations between beta-adrenergic receptor polymorphisms and cardiac function after brain death. See editorial by Salomon on page 3173.

    15. You have free access to this content
      Predictors and Outcomes of Health-Related Quality of Life in Caregivers of Cardiothoracic Transplant Recipients (pages 3387–3397)

      L. Myaskovsky, D. M. Posluszny, R. Schulz, A. F. DiMartini, G. E. Switzer, A. DeVito Dabbs, M. L. McNulty, R. L. Kormos, Y. Toyoda and M. A. Dew

      Version of Record online: 7 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04243.x

      • image
      • image

      In a prospective study of family caregivers to cardiothoracic transplant recipients, the authors find that caregivers' health-related quality of life worsened in physical functioning and pain, was predicted by several classes of psychosocial factors, and predicted transplant recipients' subsequent survival time.

    16. You have free access to this content
      Risk Factors for End-Stage Kidney Disease After Pediatric Liver Transplantation (pages 3398–3405)

      R. L. Ruebner, P. P. Reese, M. R. Denburg, E. B. Rand, P. L. Abt and S. L. Furth

      Version of Record online: 20 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04270.x

      • image
      • image

      This study of linked SRTR and USRDS data demonstrates that for pediatric liver transplant recipients, the risk of endstage kidney disease is lower than that previously reported among adults, but is highly associated with mortality and is increased among certain subgroups including older recipients, those with pretransplant kidney dysfunction, and those who subsequently received another liver transplant.

    17. You have free access to this content
      Pediatric Liver Transplantation Using Reduced and Hyper-Reduced Left Lateral Segment Grafts: A 10-Year Single-Center Experience (pages 3406–3413)

      M. R. Shehata, S. Yagi, Y. Okamura, T. Iida, T. Hori, A. Yoshizawa, K. Hata, Y. Fujimoto, K. Ogawa, S. Okamoto, Y. Ogura, A. Mori, S. Teramukai, T. Kaido and S. Uemoto

      Version of Record online: 20 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04268.x

      • image
      • image
      • image
      • image

      In a retrospective, single-center experience of pediatric living donor liver transplantation using reduced and hyperreduced left lateral segmental grafts, the authors find that use of these grafts is a feasible option with acceptable rates of graft survival and vascular complications.

    18. You have free access to this content
      Prediction Models of Donor Arrest and Graft Utilization in Liver Transplantation From Maastricht-3 Donors After Circulatory Death (pages 3414–3424)

      D. Davila, R. Ciria, W. Jassem, J. Briceño, W. Littlejohn, H. Vilca-Meléndez, P. Srinivasan, A. Prachalias, J. O’Grady, M. Rela and N. Heaton

      Version of Record online: 27 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04242.x

      • image
      • image
      • image
      • image
      • image
      • image

      The authors conduct a retrospective data analysis and prospective validation of predictive models of donor cardiac arrest and potential graft utilization in the setting of donation after circulatory determination of death for liver transplantation.

    19. You have free access to this content
      Enrichment of Regulatory T Cells in Acutely Rejected Human Liver Allografts (pages 3425–3436)

      R. Taubert, S. Pischke, J. Schlue, H. Wedemeyer, F. Noyan, A. Heim, F. Lehner, H. Barg-Hock, J. Klempnauer, S. Olek, M. P. Manns, M. Hardtke-Wolenski and E. Jaeckel

      Version of Record online: 20 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04264.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image

      This study shows, using a multicolor immunohistology technique, a disproportionate enrichment of regulatory T cells in acutely rejected human liver allografts that is distinct from the peripheral blood, and suggests active local immunoregulation even during rejection episodes.

  7. Brief Communications

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Original Articles
    8. Brief Communications
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    1. You have free access to this content
      Renal Allograft Recipients Fail to Increase Interferon-γ During Invasive Fungal Diseases (pages 3437–3440)

      D. Armstrong-James, I. Teo, S. Herbst, M. Petrou, K. Y. Shiu, A. McLean, D. Taube, A. Dorling and S. Shaunak

      Version of Record online: 13 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04254.x

      • image

      This study describes a quantitative peripheral blood assay for identifying interferon-γ deficient renal allograft recipients with invasive fungal infections who might benefit from recombinant interferon-γ therapy.

    2. You have free access to this content
      Outcomes of Steroid-Avoidance Protocols in Pediatric Kidney Transplant Recipients (pages 3441–3448)

      E. Nehus, J. Goebel and E. Abraham

      Version of Record online: 20 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04278.x

      • image
      • image
      • image

      This analysis of the United Network for Organ Sharing database demonstrates that the clinical practice of steroid avoidance in pediatric kidney transplantation is not associated with increased acute rejection or graft loss, suggesting that steroid avoidance is a reasonable approach in children at lower immunologic risk.

    3. You have free access to this content
      Differing Effects of Rapamycin or Calcineurin Inhibitor on T-Regulatory Cells in Pediatric Liver and Kidney Transplant Recipients (pages 3449–3461)

      T. Akimova, B. M. Kamath, J. W. Goebel, K. E. C. Meyers, E. B. Rand, A. Hawkins, M. H. Levine, J. C. Bucuvalas and W. W. Hancock

      Version of Record online: 20 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04269.x

      • image
      • image
      • image
      • image
      • image

      In a cross-sectional clinical study of pediatric liver and kidney transplant recipients, analysis of FOXP3+ Treg cells shows that rapamycin has beneficial effects on Treg parameters, whereas long-term and high-dose calcineurin inhibitor use may impair Treg number, function and phenotype, potentially acting as a barrier to attaining host hyporesponsiveness to an allograft.

  8. Reports From the CDC: MMWR

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Original Articles
    8. Brief Communications
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    1. You have free access to this content
      Multistate Outbreak of Fungal Infection Associated With Injection of Methylprednisolone Acetate Solution From a Single Compounding Pharmacy—United States, 2012 (pages 3462–3465)

      Version of Record online: 30 NOV 2012 | DOI: 10.1111/ajt.12041

      • image

      Epidural injections with steroids, although generally not forms used for transplant immunosuppression, that were contaminated with mold have been a significant cause of meningitis in diverse patients.

  9. Images in Transplantation

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Original Articles
    8. Brief Communications
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    1. CME

      You have free access to this content
      Persistent Anemia Following Renal Transplantation (pages 3466–3468)

      M. Eng, M. Cobb and C. M. Jones

      Version of Record online: 30 NOV 2012 | DOI: 10.1111/j.1600-6143.2012.04307.x

      • image
      • image
      • image
  10. Letters to the Editor

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Original Articles
    8. Brief Communications
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    1. You have free access to this content
      Kidney Procurement From Donors After Circulatory Death; Is There Scope for Improvement? (page 3469)

      H. M. Sammut, D. Ridgway, A. Hammad and A. Sharma

      Version of Record online: 20 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04275.x

    2. You have free access to this content
      The Quality of Procurement Data (page 3470)

      F. Ausania and D. M. Manas

      Version of Record online: 5 NOV 2012 | DOI: 10.1111/j.1600-6143.2012.04274.x

SEARCH

SEARCH BY CITATION